Allergies News and Research

Latest Allergies News and Research

Specific air pollutants linked to non-viral asthma attacks among children in urban communities

Moderate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas, a study funded by the National Institutes of Health has found.

5 Jan 2023

Genotype-first approach uncovers new relationships between genes and clinical conditions

National Institutes of Health researchers have published an assessment of 13 studies that took a genotype-first approach to patient care.

5 Jan 2023

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

4 Jan 2023

High burden of multi-food allergies among children and adults in the U.S.

A new study in the journal Annals of Allergy, Asthma & Immunology aimed to characterize the characteristics, prevalence, determinants, distribution, and psychosocial burden of multi-FA among adults and children in the US.

3 Jan 2023

Sarunashi juice and its constituting component help prevent and reduce lung cancer in mice

Lung cancer is the leading cause of death in Japan and across the globe. Among all the cancers, lung cancer has one of the lowest five-year survival rates.

28 Dec 2022

Study reveals a previously unappreciated complexity of TRM cell biology in the gut

Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.

28 Dec 2022

Researchers develop a lateral flow test to reliably identify and quantify allergens in foods

A team from the Universitat Politècnica de València, the Universitat de València, and the Centro de Investigación Biomédica en Red sobre Enfermedades Raras has developed a lateral flow test that identifies and quantifies the level of allergens reliably in food with the help of a smartphone.

23 Dec 2022

Research sheds light on how mRNA boosters affect the durability of antibodies to COVID-19

New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.

22 Dec 2022

Brief roundup of research done by experts at UCLA Health

Below is a brief roundup of news and story ideas from the experts at UCLA Health.

21 Dec 2022

ACAAI’s two new yardsticks on managing eosinophilic esophagitis and cough published

Beginning in 2016, the American College of Allergy, Asthma and Immunology (ACAAI) began developing a series of yardsticks to help practitioners better understand the range of treatments available for allergic conditions.

21 Dec 2022

MHRA authorizes the COVID-19 vaccine developed by Sanofi

VidPrevtyn Beta, the COVID-19 vaccine developed by Sanofi, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

21 Dec 2022

Persistent smell loss mostly prevalent among long Covid patients

Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia.

20 Dec 2022

Recent surge in group A streptococcal infections among children in UK

In an editorial published in the journal New Microbes and New Infections, scientists have highlighted the possible reasons behind a sudden rise in cases of group A streptococcal infections among children in the United Kingdom and other European countries.

18 Dec 2022

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

Researchers investigated whether coronavirus disease 2019 (COVID-19)-associated chemosensory alterations were predictive of serological responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among United States (US) residents.

16 Dec 2022

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results published today in the New England Journal of Medicine.

15 Dec 2022

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

9 Dec 2022

Study shows how an inflammatory molecule causes life-threatening airway damage in asthma patients

An inflammatory molecule called LIGHT, appears to be the cause of life-threatening airway damage in patients with severe asthma.

9 Dec 2022

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

8 Dec 2022

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

New research shows that the closest bat virus relatives of the human Middle-East Respiratory Syndrome (MERS) coronavirus efficiently bind to bat ACE2 receptors as an entry point into these cells.

8 Dec 2022

Allergies News and Research

Latest Allergies News and Research

Specific air pollutants linked to non-viral asthma attacks among children in urban communities

Genotype-first approach uncovers new relationships between genes and clinical conditions

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

High burden of multi-food allergies among children and adults in the U.S.

Sarunashi juice and its constituting component help prevent and reduce lung cancer in mice

Study reveals a previously unappreciated complexity of TRM cell biology in the gut

Researchers develop a lateral flow test to reliably identify and quantify allergens in foods

Research sheds light on how mRNA boosters affect the durability of antibodies to COVID-19

Brief roundup of research done by experts at UCLA Health

ACAAI’s two new yardsticks on managing eosinophilic esophagitis and cough published

MHRA authorizes the COVID-19 vaccine developed by Sanofi

Persistent smell loss mostly prevalent among long Covid patients

Recent surge in group A streptococcal infections among children in UK

Exploring taste and smell dysfunction as strong predictors of SARS-CoV-2 infections

The UK's growing burden of long-COVID

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Study shows how an inflammatory molecule causes life-threatening airway damage in asthma patients

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Allergies News and Research

Latest Allergies News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in